Blog

Anacura Expands Services with OHMXbio Acquisition
📢 Anacura acquires OHMX.bio! Expanding services in drug discovery and diagnostics research. Strengthening biotech community with personalized lab solutions.

Cellular Origins Acquires ACTIA Platform IP Revolutionizing Cell Therapy Manufacturing
1. 📣 Exciting news! Cellular Origins acquires ACTIA Platform IP for cell therapy manufacturing, revolutionizing the industry! 🧪 2. 🚀 Accelerate your cell therapy manufacturing with Cellular Origins' robotic solution, Constellation™. The future is here! 3. 💡 Introducing Constellation™ - the scalable system that integrates automation robotics and aseptic fluid-handling technologies. 4. 👩🔬 Breakthrough acquisition! Cellular Origins solves the challenge of large-scale cell therapy production with ACTIA Platform.

Sustainability in Biomanufacturing: The Key Challenges
🌱🌍 Biomanufacturers are in the early stages of sustainability practices. Defining sustainability and its measurement is crucial. ♻️💧

Clean Bioprocessing: How to Ensure Safety and Efficacy
🔍 Bioprocessing equipment must be sterilized to ensure safety and efficacy. ✅ Manufacturers should consider sterilization during design. ✨ Methods are continually refined.

Boosting Yeast Growth and Titer with Green Supplementation
💡 Researchers at UCD found that supplementing yeast spent media enhances titer and growth, promoting a circular green economy. 🌿🧪🧫👩🔬🌍

EMA Approves 10 New Life-Changing Medicines!
📢 EMA's CHMP recommended 10 medicines for approval in June 2024, including Balversa, Eurneffy, and mResvia. 💊👃💉

Belgian MedTech Firm Nyxoah Secures €375m Loan for Sleep Apnea Innovation
🚀 Belgian medical tech company Nyxoah secures €37.5m loan from European Investment Bank for R&D and manufacturing expansion. ✨🔬💡

Revolutionizing Biology: Visualizing Complex Systems with Colorful Precision
🔬🧪 Spatial biology is evolving with high-plex fluorescent labeling technology, expanding its boundaries. 🌟🔍🌈🧬 This advancement has revolutionary potential. 💡🌍







